ACSChemNeurosci
@ACSChemNeurosci
Followers
4K
Following
555
Media
321
Statuses
2K
This account is no longer active or monitored. For updates about ACS Chemical Neuroscience, follow @ACSPublications and @ACSBioMed.
Washington, DC
Joined August 2009
This account will no longer be active or monitored. We welcome our community to follow @ACSPublications or sign up for e-Alerts for future updates from ACS Chemical Neuroscience:
0
0
1
Don't miss out on this exciting discussion! . This collection from #ACSChemNeuro dives into the research around #MDMA as a potential breakthrough therapy. Read the latest research ➡
0
0
0
RT @ACSPublications: Next week is World #AntimicrobialResistance Awareness Week! Join us for a webinar discussing the cutting edge work bei….
0
8
0
RT @ketspatel10: Check out our recent works on Chronic pain published @ACSChemNeurosci.A great collaboration between @DarrenDerksen lab and….
0
2
0
Don't miss out on this exciting discussion! . This collection from #ACSChemNeuro dives into the research around #MDMA as a potential breakthrough therapy. Read the latest research ➡
1
0
0
Curious about the latest research on MDMA treatments? Check out our recent collection of articles on the subject ➡
The psychedelic treatment, for PTSD, was rejected last week by government regulators.
0
0
0
RT @ACSBioMed: ❗ LAST CALL! Call for Papers: ACS Pharmacology and Translational Science invites submissions for a Virtual Special Issue on….
0
1
0
RT @MaykeAlencar: I am proud to have collaborated with @cahhcardi et al in this amazing paper now published in @ACSChemNeurosci. Link: h….
0
2
0
📢Stay up to date with the latest📢 This new collection of #ACSChemNeuro research joins the discussion around #MDMA as a potential breakthrough therapy. Read the latest research ➡
0
0
1
📢Stay up to date with the latest📢 This new collection of #ACSChemNeuro research joins the discussion around #MDMA as a potential breakthrough therapy. Read the latest research ➡
0
0
1
RT @Aditya_singh97: Read our latest review on the gut-microbiome brain axis in Parkinson’s disease and role of “biotics” approach #neurosci….
pubs.acs.org
Parkinson’s disease, a classical motor disorder affecting the dopaminergic system of the brain, has been as a disease of the brain, but this classical notion has now been viewed differently as the...
0
1
0
📢Stay up to date with the latest📢 This new collection of #ACSChemNeuro research joins the discussion around #MDMA as a potential breakthrough therapy. Read the latest research ➡
0
2
4
RT @IOCBPrague: #research.Parallel Metabolomics and Lipidomics of a PSMA/GCPII Deficient Mouse Model Reveal Alteration of NAAG Levels and B….
pubs.acs.org
Glutamate carboxypeptidase II (GCPII, also known as PSMA or FOLH1) is responsible for the cleavage of N-acetyl-aspartyl-glutamate (NAAG) to N-acetyl-aspartate and glutamate in the central nervous...
0
4
0
RT @realJacobBell: To sum up today's adcomm: While the experts saw potential in the use of MDMA-assisted therapy in the treatment of PTSD,….
0
1
0
FDA Advisory Committee votes against recommending Lykos' #MDMA treatment for PTSD. Read our latest MDMA research here ➡
0
2
3
Fascinating discussions online today surrounding the FDA's consideration of a new #MDMA treatment for PTSD 🤔. When is a double-blinded study not enough? How can you blind for a treatment that includes such pronounced and well-known effects?. Let us know what you think! ⬇.
1
4
4
📢New collection of #ACSChemNeuro research as the FDA is expected to announce a decision on a new treatment involving #MDMA today ⏰. Read the latest research ➡
0
4
6
RT @eric_sparkes: It's all things adamantane in our (@Lambert_Usyd) latest synthetic cannabinoid work, out now in @ACSChemNeurosci!. We syn….
pubs.acs.org
Synthetic cannabinoid receptor agonists (SCRAs) are a growing class of new psychoactive substances (NPS) commonly derived from an N-alkylated indole, indazole, or 7-azaindole scaffold. Diversificat...
0
4
0
RT @kwanalexc: This study builds on our @ACSChemNeurosci paper last year, where @PashaDavoudian mapped c-Fos response in the brain after ps….
pubs.acs.org
Psilocybin is a psychedelic with therapeutic potential. While there is growing evidence that psilocybin exerts its beneficial effects through enhancing neural plasticity, the exact brain regions...
0
2
0